X4 Pharmaceuticals, Inc. (XFOR) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for X4 Pharmaceuticals, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:06.040 Greetings and welcome to the X4 Pharmaceuticals First Quarter 2025 Financial 00:00:06.040 -- 00:00:11.088 and Operating Results Conference Call. At this time, all participants are in 00:00:11.088 -- 00:00:17.679 a listen-only mode. A question and answer session will follow the formal presentation. 00:00:17.679 -- 00:00:20.443 As a reminder, this conference call is being recorded. 00:00:20.443 -- 00:00:21.886 It 00:00:21.886 -- 00:00:27.314 is now my pleasure to introduce your host, Dan Ferry from LifeSci Advisors. 00:00:27.314 -- 00:00:29.595 Please begin. 00:00:29.630 -- 00:00:33.055 Thank you, operator, and good morning, everyone. 00:00:33.055 -- 00:00:37.180 Presenting on today's call will be X-Force Chief Executive Officer, Dr. 00:00:37.180 -- 00:00:42.167 Paula Reagan, and Chief Financial Officer, Adam Mostafa. 00:00:42.167 -- 00:00:47.054 Following prepared remarks by each, we will open the call to your questions, and we'll 00:00:47.054 -- 00:00:52.361 be joined by Chief Commercial Officer, Mark Baldry, and Chief Medical Officer, Dr. 00:00:52.361 -- 00:00:55.445 Christoph Arbit Engels. 00:00:55.445 -- 00:00:59.532 As a reminder, on today's call, the company will be making forward-looking statements 00:00:59.532 -- 00:01:03.677 regarding regulatory and product development plans. 00:01:03.677 -- 00:01:06.962 These statements are subject to risks and uncertainties that may cause actual results 00:01:06.962 -- 00:01:10.006 to differ from those forecasted. 00:01:10.006 -- 00:01:15.933 A description of these risks can be found in X4's most recent filings with the SEC, 00:01:15.933 -- 00:01:22.779 including last year's Form 10-K and this past quarter's Form 10-Q, 00:01:23.102 -- 00:01:27.628 which is expected to be filed after marke...